Efficacy of HPV vaccine in preventing of increasing cervical lesion

Efficacy of HPV vaccine in preventing of increasing cervical lesion in abnormal Pap test

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190603043801N1

Enrollment

242

Registered

2019-07-24

Start date

2011-08-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical cancer. Cervical cancer

Interventions

Intervention 1: In the Intervention group, women received three dosages of HPV vaccination. Intervention 2: In control group, women did not receive any dosages of HPV vaccination.

Eligibility

Sex/Gender

Female

Age

22 Years to 50 Years

Inclusion criteria

Inclusion criteria: Women suffering from various degrees of cervical lesions ( CIN 1, 2, 3)

Exclusion criteria

Exclusion criteria: Pregnant women Women with severe allergies

Design outcomes

Primary

Measure	Time frame
Clinical finding. Timepoint: At 1, 7, 12, 18, 24 months. Method of measurement: Gynecological examination.;Pap tests results. Timepoint: At 1, 7, 12, 24 months. Method of measurement: Pap smear Testing.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMojgan Karimi -Zarchi

Yazd University of Medical Sciences

drkarimi2001@yahoo.com+98 21 6435 2680

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 28, 2026